Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.
about
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practiceAMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysisImpact of cancer therapies on ovarian reserveAntimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraceptionRelationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in womenFSH and its second messenger cAMP stimulate the transcription of human anti-Müllerian hormone in cultured granulosa cells.Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplantOxidative Stress Markers in GnRH Agonist and Antagonist Protocols in IVF.Oocyte polarized light microscopy, assay of specific follicular fluid metabolites, and gene expression in cumulus cells as different approaches to predict fertilization efficiency after ICSI.Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulationAnti-Müllerian hormone levels in the follicular fluid of the preovulatory follicle: a predictor for oocyte fertilization and quality of embryo.Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHHMüllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumorsComparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome.The use of ovarian reserve markers in IVF clinical practice: a national consensus.FOXL2 Is an Essential Activator of SF-1-Induced Transcriptional Regulation of Anti-Müllerian Hormone in Human Granulosa Cells.Testing for Ovarian Reserve in Assisted Reproduction programs: the current point of view.Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal womenTo what extent does Anti-Mullerian Hormone contribute to a better prediction of live birth after IVF?Prediction of reproductive outcomes according to different serum anti-Müllerian hormone levels in females undergoing intracystoplasmic sperm injectionReduced neurotrophin receptor tropomyosin-related kinase A expression in human granulosa cells: a novel marker of diminishing ovarian reserve.Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone.Age-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women.Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization.What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSISerum anti-Müllerian hormone levels as a predictor of the ovarian response and IVF outcomesFemale age in ART: when to stop?Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome.Maximum basal FSH predicts reproductive outcome better than cycle-specific basal FSH levels: waiting for a "better" month conveys limited retrieval benefitsThe effect of abdominal radical trachelectomy on ovarian reserve: serial changes in serum anti-müllerian hormone levelsFertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments.Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR.Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation.Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study.Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF.Attenuated AMH signaling pathway plays an important role in the pathogenesis of ovarian hyperstimulation syndrome.Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
P2860
Q26829747-BC0B2909-46DA-4BE0-9FB9-376987FAB956Q28289118-D8FB306F-6049-4FF4-B445-64749D0202FFQ28384958-D4984EFD-9BB8-4D48-A72D-FF53BC2B9501Q28393325-7E014658-8253-4ED4-9521-65158D6D8928Q30361786-10D3CD37-79E9-4EC7-A674-1CADE0E75E03Q30439646-C2402D7C-52C4-4143-B80C-13B57318A04DQ33636964-F3D3795D-8220-4305-98FC-B66EB1B06219Q33744885-39C750B3-A597-4D85-B732-5F040138F3A0Q33801073-F0E11391-B0D8-42BD-B997-0FC4270091D9Q33827655-179FCA5F-2CBF-4AE6-A8C6-8E0C6E8B04BEQ34116423-DAB76F5E-03BC-40AB-A73E-3B9D0BAEC720Q34208331-EA1C0114-CEF3-49F4-843B-954FD948B519Q34226336-E5490BD2-1E8A-4822-9803-BD2EB227CEDEQ34246272-03F343A1-FAC1-472F-AE6A-2B0D0C02F004Q34363167-F2E90DAB-1EEA-485F-9141-3A837B575807Q34500365-043B8775-9849-42F0-A54F-A86D41708637Q34534140-3C4E75F6-8FDE-4E4E-9DC5-A7D9E4138FF6Q34608174-64BE6D2D-E68B-47C6-99F4-B3B693D304FBQ34618818-0998A91D-37C6-4256-B089-A9740B04AC74Q34962726-966FF70E-4117-49A7-A2C7-42739E534215Q34999705-EFD2CF28-51CA-44E4-AE98-8BD8075C73B8Q35126929-C6C527A5-B21E-47EE-9442-2B5B9824A42FQ35181958-6E38E5FC-74F2-42B8-9854-A1F36BB9DA46Q35538995-670AED7D-1147-4BF9-8BD5-74778D1A17ABQ35742140-0F7B2631-429E-4E90-A37D-7C7549D86FDBQ35750252-A1B68CD8-AE99-49FC-9380-EAC3A1A69652Q35763800-A824F8D7-5CC1-4C70-9C20-B89797B7E4B5Q35767824-7D19EFD2-BA7B-43E6-983A-495532D1CCFDQ35884557-7C7EEDD4-9BD2-438E-8923-E4D50FB91C34Q35898934-23361F49-C844-473B-B0DD-236E98DAE82FQ35953736-C539ACFA-5C58-464F-8A6D-71C7494DA5C1Q35966464-3A3D5308-62FE-4FCD-9B80-033FBE705955Q35966481-94AE968D-50B3-46E5-B6C7-BEE35ED18B75Q35976287-84B133EA-DDDD-4A8B-A43A-94CA09F105AAQ36024000-476C0B8C-B907-4C5F-8662-E4E30B1988BFQ36045426-91689EB3-3595-4D0D-A9F8-FE201A1AD50AQ36074219-4E2CC643-1624-4982-893B-2A20AFCE885BQ36270584-E949DCC2-4C27-4180-A3B8-647DC110FB32Q36309513-D70E569A-3BA4-4F96-A32E-D932610B9BE1Q36483196-01D771C3-C8A5-465E-9CA5-9C9A527BD37E
P2860
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Early follicular serum mülleri ...... eproductive technology cycles.
@en
Early follicular serum mülleri ...... eproductive technology cycles.
@nl
type
label
Early follicular serum mülleri ...... eproductive technology cycles.
@en
Early follicular serum mülleri ...... eproductive technology cycles.
@nl
prefLabel
Early follicular serum mülleri ...... eproductive technology cycles.
@en
Early follicular serum mülleri ...... eproductive technology cycles.
@nl
P2093
P1476
Early follicular serum mülleri ...... eproductive technology cycles.
@en
P2093
Benjamin P Christian
David T MacLaughlin
Robert M Shelden
P304
P356
10.1016/S0015-0282(01)03201-0
P407
P577
2002-03-01T00:00:00Z